Prognos Health

New York, NY · Founded 2010 · Privately Held (backing)

Developer of a healthcare analytics platform designed to utilize patient-level data to derive clinical insights. Prognos Health is based in New York, NY and was founded in 2010. It has raised $66.5 million across 2 recorded rounds; the latest was a $23.3 million early-stage round in Apr 2023.

Last price · $/share
—
Implied valuation
—
Total raised
$66.5M
Last round
Early Stage VC
Apr 2023

Prognos Health key facts

  • Developer of a healthcare analytics platform designed to utilize patient-level data to derive clinical insights.
  • It has raised $66.5M across 2 recorded rounds; the latest was Early Stage VC ($23.3M) in Apr 2023.
  • Notable investors include Labcorp Venture Fund, MSD Global Health Innovation Fund, Marshall Wace, Montage Capital, Maywic Select Investments — 16 tracked in total.
  • Prognos Health has filed 3 Form Ds with the SEC since 2017, most recently May 2023 ($23.3M sold to 10 investors).
  • Status: Privately Held (backing).
Free account
More of Prognos Health with a free account
  • ·The complete investor list: 16 names
  • ·Watch Prognos Health: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Prognos Health funding rounds

2 rounds
Apr 2023Early Stage VC$23.3MSEC filing▮
Nov 2017Early Stage VC$17.0MSEC filing▮

How much has Prognos Health raised?

Prognos Health has raised $66.5 million in total; 2 of its rounds are on record. The largest on record was a $23.3 million early-stage round in Apr 2023.

Prognos Health has filed 3 Form Ds with the SEC since 2017, most recently in May 2023 ($23.3 million sold to 10 investors).

Prognos Health investors

16 investors are on record for Prognos Health, including Labcorp Venture Fund, MSD Global Health Innovation Fund, Marshall Wace and Montage Capital. By type, the record holds 4 venture capital firms and 1 hedge fund. The early-stage round in Apr 2023 drew 10 investors.

About Prognos Health

Developer of a healthcare analytics platform designed to utilize patient-level data to derive clinical insights. The company's platform leverages de-identified patients, multi-lab test data results, open and closed medical claims, as well as data to empower precise decision-making at all stages of the brand lifecycle and member enrollment, enabling medical companies to align brand strategy and risk assessment to clinical treatment decisions.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2010
Employees
61
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation — not yet priced

Prognos Health doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.